期刊文献+

和肽素在下呼吸道感染中的临床应用 被引量:4

Clinical application of copeptin in lower respiratory tract infection
原文传递
导出
摘要 作为一种生物标志物,和肽素用于抗利尿激素释放的测定.近年研究表明,和肽素有望成为一种较为理想的炎性标志物,应用于下呼吸道感染的诊治.在社区获得性肺炎、慢性阻塞性肺疾病急性加重等下呼吸道感染中,血和肽素水平明显升高,与疾病严重程度和预后密切相关. As a biomarker,copeptin is used to measure arginine vasopressin release. Recent studies show that copeptin is expected to be an ideal inflammatory marker and used for diagnosis and treatment of lower respiratory tract infection. In community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease and other lower respiratory tract infections, blood copeptin level significantly increases and is closely related with severity and prognosiy of the diseases.
出处 《国际呼吸杂志》 2010年第20期1254-1256,共3页 International Journal of Respiration
关键词 和肽素 下呼吸道感染 临床应用 Copeptin Lower respiratory tract infection Clinical application
  • 相关文献

参考文献18

  • 1Christ-Crain M,Stolz D,Bingisser R,et al.Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia:a randomized trial.Am J Respir Crit Care Med,2006,174:84-93.
  • 2Papassotiriou J,Morgenthaler NG,Struck J,et al.Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma.Clin Chem,2006,52:1144-1151.
  • 3Acher R,Chauvet J,Rouille Y.Dynamic processing of neuropeptides:sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport.J Mol Neurosci,2002,18:223-228.
  • 4Barat C,Simpson L,Breslow E.Properties of humanvasopressin precursor constructs:inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus.Biochemistry,2004,43:8191-8203.
  • 5Valli G,Fedeli A,Antonucci R,et al.Water and sodium imbalance in COPD patients.Monaldi Arch Chest Dis,2004,61:112-116.
  • 6Preibisz JJ,Sealey JE,Laragh JH,et al.Plasma and platelet vasopressin in essential hypertension and congestive heart failure.Hypertension,1983,5:1129-1138.
  • 7Morgenthaler NG,Struck J,Alonso C,et al.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin.Clin Chem,2006,52:112-119.
  • 8Müller B,Morgenthaler N,Stolz D,et al.Circulating levels of copeptin,a novel biomarker,in lower respiratory tract infections.Eur J Clin Invest,2007,37:145-152.
  • 9赵云峰,林勇,张卫国.社区获得性肺炎患者血清合肽素测定的临床意义[J].中华结核和呼吸杂志,2009,32(12):911-914. 被引量:7
  • 10Krüger S,Ewig S,Kunde J,et al.C-terminal provasopressin (copeptin) in patients with community-acquired pneumoniainfluence of antibiotic pre-treatment:results from the German competence network CAPNETZ.J Antimicrob Chemother,2009,64:159-162.

二级参考文献29

  • 1丁续红,吴小军,余昌平,胡苏萍.慢性阻塞性肺病急性加重期C反应蛋白测定的临床价值[J].武汉大学学报(医学版),2006,27(5):660-663. 被引量:15
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3040
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 4Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 2004,23 : 932-946.
  • 5Volanakis JE. Human C-reactive protein: expression, structure,and function. Mol Immunol,2001,38:189-197.
  • 6Pepys MB. C-reactive protein fifty years on. Lancet, 1981,1 : 653-657.
  • 7Okamura JM, Miyagi JM, Tenada K, et al. Potential clinical applications of C-reactive protein. J Clin Lab Anal, 1990,4: 231-235.
  • 8Almirall J, Bolibar I,Toran P,et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest, 2004,125 : 1335-1342.
  • 9Garcia Vdzquez E, Martinez JA, Mensa J, et al. C-reaetive protein levels in community-acquired pneumonia. Eur Respir J, 2003,21 : 702-705.
  • 10Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med, 1998,92 :684-667.

共引文献23

同被引文献34

  • 1Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin, C-re- active protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD[ J]. Chest, 2007,131 (4) : 1058-1067.
  • 2Tofan F, Rahimi-Rad MH, Rasmi Y. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmona- ry disease[J]. Pneumologia, 2012,61 (3) : 160-162.
  • 3Gomez FP, Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease. guidelines for chronic obstructive pulmonary disease[J]. Curt Opin Pulm Med,2002,8(2) :81-86.
  • 4Morgenthaler NG, MUller B, Struck J, et al. Cope- ptin,a stable peptide of the arginine vasopressin pre- cursor,is elevated in hemorrhagic and septic shock [J]. Shock,2007,28(2) ,219-226.
  • 5Barczyk A, Pierzchala W, Kon OM, et al. Cytokine production by bronchoalveolar lavage T lyrnphocytes in chronic obstructive pulmonary disease[J]. J Aller- gy Clin Immunol, 2006,117(6) : 1487-1492.
  • 6Weis N,Almdal T. C-reactive protein: can it be used as a marker o{ in{ection in patients with exacerbation of chronic obstructive pulmonary disease[J]. Eur J Intern Med,2006,17(2) :88-91.
  • 7Ramamoorthy RD, Nallasamy V, Reddy R, et al. A review of C-reactive protein: A diagnostic indicator in periodontal medicine[J]. J Pharm Bioallied Sci, 2012,4(2) : 422-426.
  • 8付强,况九龙,施德全.C反应蛋白在慢性阻塞性肺疾病急性加重期中的临床意义[J].国际呼吸杂志,2009,29(15):897-900. 被引量:14
  • 9张勇,朱述阳,韩兆勇,刘平莉.社区获得性肺炎患者血清瘦素水平变化及其与C反应蛋白和降钙素原的相关性研究[J].实用医学杂志,2011,27(21):3863-3866. 被引量:24
  • 10方明,张琳,王道标,袁慧峰,章车明.急性肺损伤患者血清及肺泡灌洗液和肽素水平变化的临床分析[J].中华危重症医学杂志(电子版),2011,4(3):13-18. 被引量:10

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部